Zhe Sun

Statistics

Publications

Citations

139

H-Index

Active since

2022

Affiliations

XCell Science (United States)(Current)

Zhe Sun is an author at XCell Science (United States) specializing in immunotherapy, chimeric antigen receptor t cell manufacturing, and acute leukemia cellular therapy.

Publications per year

2022–2022

Publications

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Junfang Yang, Jiaping He, Xian Zhang et al. · Blood Cancer Journal · 2022 · 100 citations · Full text

Medicine, Hematology, Oncology +17

Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia

Cheng Zhang, Jiaping He, Li Liu et al. · Blood Cancer Journal · 2022 · 39 citations · Full text

Medicine, Oncology, Pharmacokinetics +14

1–2 of 2